Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lucia Di Marzo
Observed name:
DI MARZO, LUCIA
Institution:
University of Bari Aldo Moro
Observed institution:
University of Bari Aldo Moro
ORCID:
0009-0006-3737-9837
Observed ORCID:
0009-0006-3737-9837
OpenAlex ID:
A5103823852
Microenvironment drug resistance in multiple myeloma: emerging new players
2016
·
Lucia Di Marzo
, Vanessa Desantis
, et al.
·
Oncotarget
·
189
PDF
Cancer Associated Fibroblasts and Tumor Growth: Focus on Multiple Myeloma
2014
·
Kim De Veirman
, Luigia Rao
, et al.
·
Cancers
·
102
PDF
Bone marrow fibroblasts overexpress miR‐27b and miR‐214 in step with multiple myeloma progression, dependent on tumour cell‐derived exosomes
2018
·
Maria Antonia Frassanito
, Vanessa Desantis
, et al.
·
The Journal of Pathology
·
95
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target?
2018
·
Ilaria Saltarella
, Maria Antonia Frassanito
, et al.
·
Neoplasia
·
35
PDF
Myeloma cells regulate miRNA transfer from fibroblast‐derived exosomes by expression of lncRNAs
2021
·
Ilaria Saltarella
, Aurelia Lamanuzzi
, et al.
·
The Journal of Pathology
·
28
Myeloma cells act as tolerogenic antigen‐presenting cells and induce regulatory T cells in vitro
2014
·
Maria Antonia Frassanito
, Simona Ruggieri
, et al.
·
European Journal Of Haematology
·
27
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma
2018
·
Vanessa Desantis
, Maria Antonia Frassanito
, et al.
·
Annals of Hematology
·
19
Genomic profiling at a single center cracks the code in inborn errors of immunity
2025
·
Alessandro Andriano
, Vanessa Desantis
, et al.
·
Internal and Emergency Medicine
·
3
PDF
Progressive NK-cell dysfunction and ILC imbalance favor immune evasion in multiple myeloma
2025
·
Maria Teresa Bilotta
, Antonio Giovanni Solimando
, et al.
·
Blood Advances
·
1
PDF
Integrating clinical and economic outcomes in the elderly myeloma management: a comparative cost-effectiveness analysis
2026
·
Antonio G. Solimando
, Vanessa Desantis
, et al.
·
Frontiers in Oncology
PDF
Show more works
View as search
Works count:
11
Citation count:
499
H-index:
7
I10-index:
7
Year
Topic
Type